Search

Filters

Clear All
  • 49
  • 60
  • 6
  • 3
  • 498

Phase

  • 18
  • 15
  • 3
  • 15
  • 6
  • 15
  • 2
  • 439
  • 582
  • 229
  • 606
  • 10
  • 56
  • 27
  • 1
  • 615

Found 616 results

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Multisensory processing in the elderly

18 years - 100 years
All genders
This research is being done to investigate multisensory processing in young and older adults.

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

1 years - 21 years
All genders
This screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has …

A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement

All genders
This pilot phase II trial studies the side effects of azacitidine and combination chemotherapy in infants with acute lymphoblastic leukemia and KMT2A gene rearrangement.

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors Including CNS Tumors

2 years - 21 years
All genders
In this study, you will receive the combination of lenvatinib with everolimus. The main purpose of this study is: To study the effects of this combination of study drugs on your body To determine the highest safe dose of study drugs that can be given in combination To determine what …

A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors

18 years - 100 years
All genders
The purpose of this study is to evaluate the safety of the study drug LY3381916 administered alone or in combination with anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody (LY3300054).

Personal Exposures to Semi-Volatile Organic Compounds in Children of Alaska Native communities

6 years - 10 years
All genders
The purpose of this study is to investigate personal exposure to a group of semi-volatile chemicals in children of Alaska Native communities.

BRCAAway: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

18 years - 100 years
Male
The purpose of this study is to study two US FDA approved drugs alone and in combination with each other in people who have mCRPC and DNA repair defects.

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients

3 years - 21 years
All genders
This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in treating patients with newly diagnosed type of brain tumor called WNT)/Wingless (WNT)-driven medulloblastoma.

Human Alcohol Seeking Despite Aversion

21 years - 55 years
All genders
The purpose of this study is to determine the relationship between the response to visual (images) and/or auditory (sound) stimuli and alcohol related behavior.

Gendered Speech and Perception

18 years - 35 years
All genders
The purpose of this project is to study the expectations of speech, created by information about the speaker, and its effect on speech perception.
221 - 230 of 616